Results 71 to 80 of about 3,661 (213)

Elasticity Improvement and Water Loss Prevention in Vulvar Skin by Topical Nonhormonal Moisturizer

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Postmenopausal vulvovaginal symptoms due to estrogen depletion are very common. Many women prefer over‐the‐counter (OTC), Nonhormonal products containing few or no additives. Objectives We investigated the effect of a topical Nonhormonal moisturizer containing just mineral oil, white beeswax, emollients, and water.
Hans Christian Wulf   +2 more
wiley   +1 more source

Carbon Dioxide Laser Vulvovaginal Rejuvenation: A Systematic Review

open access: yesCosmetics, 2021
Genitourinary syndrome of menopause (GSM) causes significant symptomatic aggravation that affects the quality of life (QoL). Vulvovaginal atrophy (VVA), the hallmark of GSM, is managed with topical non-hormonal therapy, including moisturizers and ...
Tassahil Messas   +2 more
doaj   +1 more source

The Role of Vaginal Oestrogen Therapy in Postmenopausal Women With Pelvic Organ Prolapse: Does It Have Any Impact on Perioperative Outcomes? A Systematic Review of Randomised Controlled Trials

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Pelvic organ prolapse (POP) affects up to 50% of postmenopausal women, negatively impacting sexual function and quality of life. While surgery remains the primary treatment, increasing attention has been given to perioperative vaginal oestrogen therapy and its potential impact on surgical outcomes.
Gilda Sicilia   +7 more
wiley   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

An Exploration of the Views and Perspectives of Australian Trans and Gender Diverse Individuals About Transvaginal Ultrasound

open access: yesPerspectives on Sexual and Reproductive Health, EarlyView.
ABSTRACT Background Transvaginal ultrasound (TVS) is used routinely in gynecological care in Australia to manage gynecological health concerns. Typically, TVS is well tolerated by patients, with low levels of discomfort reported. Trans and gender diverse people assigned female at birth may experience gender dysphoria or testosterone‐related anatomical ...
Caitlyn Wilke   +5 more
wiley   +1 more source

Vaginal Health in Menopausal Women [PDF]

open access: yes, 2019
The aim of this review is to provide an overview of genitourinary health in peri- and postmenopause, particularly of vulvovaginal atrophy (VVA), which is part of genitourinary syndrome (GSM).
Giulia Gava   +6 more
core   +1 more source

Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors. [PDF]

open access: yes, 2021
Adjuvant chemotherapy and endocrine therapy can induce early iatrogenic menopause or worsen pre-existing menopausal symptoms in breast cancer survivors (BCS).
Fabrizio Bert   +5 more
core   +1 more source

Probiotic‐Based Materials as Living Therapeutics

open access: yesAdvanced Materials, Volume 38, Issue 1, 2 January 2026.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio   +2 more
wiley   +1 more source

Genitourinary syndrome of menopause: optimization of therapyfor vaginal symptoms [PDF]

open access: yesГинекология, 2018
The aim of the study was to investigate the dynamics of atrophic changes оn the use of low-dose regimens of local therapy with a druge containing only estriol and a druge containing estriol, progesterone and a culture of lactobacilli in patients with ...
E G Eprikyan   +3 more
doaj   +1 more source

Current treatment options for postmenopausal vaginal atrophy [PDF]

open access: yes, 2019
Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%-60% of postmenopausal women who are suffering in silence from this condition. Hormonal changes, especially hypoestrogenism inherent in menopause, are characterized by a variety of ...
Castelo-Branco Flores, Camil   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy